CCCR News and Updates
1 - 10 of 48
Five Proposals Receive Seed Funds to Develop Medical Devices for Children
Published on in CHOP News
Pennsylvania Pediatric Medical Device Consortium supports projects addressing infant feeding development, neonatal jaundice, pediatric dysphagia, unplanned extubations, and adrenal crisis
Small Study Shows Convalescent Plasma is Safe to Use in Pediatric Patients with COVID-19
Published on in CHOP News
CHOP researchers show convalescent plasma appears to be a safe and possibly effective treatment for children with life-threatening cases of COVID-19.
New Treatment Shows Success in High-Risk Solid Tumors
Published on in CHOP News
The CHOP-engineered therapy overcomes common drug resistance and has potential to elicit fewer toxicities than most cancer treatments.
CHOP Researchers Uncover Mechanism that Helps Adenovirus Replicate Efficiently in Host Cells
Published on in CHOP News
In a study published in Nature Microbiology, CHOP researchers uncover a ubiquitination mechanism that helps adenovirus replicate efficiently in host cells.
Children’s Hospital of Philadelphia Announces Endowed Chair in Pediatric Neuroblastoma Research
Published on in CHOP News
CHOP recipient, physician-scientist Dr. Yael Mossé, is innovating targeted, less toxic therapies for cancer affecting mostly infants and young children.
A Cancer-causing Gene May Benefit Patients During Chemotherapy
Published on in CHOP News, Cancer Connections
CHOP researchers report that a well-known gene that normally drives cancer could potentially benefit cancer patients if used in combination with chemotherapy.
Single Cell Technology Zooms In for Clearer View of High-risk Pediatric Cancers
Published on in CHOP News
CHOP researchers were awarded a five-year research grant totaling $12.5 million to create the Center for Pediatric Tumor Cell Atlas as part of a 10-centernational consortium.
CHOP’s Breakthrough Cancer Immunotherapy Program Receives Generous Grant from the Emily Whitehead Foundation
Published on in CHOP News, Cancer Connections
Emily Whitehead, the first pediatric patient to receive CAR T-cell therapy, and her family honor the CHOP team who saved her life with a $250,000 research grant to expand the use of the therapy for relapsed or refractory ALL.
Pediatric Cancers Differ from Adult Cancers, and Need Different Treatment Plans, Say CHOP Experts
Published on in CHOP News
A new study finds important differences in how cancers develop in children as compared to adults, proving the concept that childhood cancers are not "small adult tumors."
T-cell Therapy Pioneered at CHOP Shows Persistent Benefits in Young Leukemia Patients
Published on in CHOP News, Cancer Connections
Updated results from a global clinical trial of the CAR T-cell therapy for ALL reveal that children and young adults continued to show high rates of durable, complete remission of their disease.